GEN has signed an important partnership and collaboration agreement with Jaguar Health.…
userMarch 20, 2024
GEN initiates Phase 1 study of the first-in-class investigational drug SUL-238 Ankara,…
userFebruary 22, 2024
As one of Türkiye's fastest-growing pharmaceutical companies, we are pleased to be…
userSeptember 4, 2023
GEN 2022 Sustainability Report has been published in accordance with GRI standards.…
userAugust 17, 2023
